Clinical Utility of Combined Optical Genome Mapping and 523-gene Next Generation Sequencing Panel For Comprehensive Evaluation of Myeloid Cancers

Nikhil Shri Sahajpal, Ashis K Mondal, Sudha Ananth, Daniel Saul, Soheil Shams, Alex R Hastie, Natasha M. Savage, Vamsi Kota, Alka Chaubey, Ravindra Kolhe
doi: https://doi.org/10.1101/2022.01.15.22269355

Article usage

Article usage: January 2022 to December 2024

AbstractFullPdf
Jan 2022109324330
Feb 202251518147
Mar 20222588103
Apr 2022217862
May 202211521207
Jun 2022861065
Jul 2022632481
Aug 2022751639
Sep 2022862132
Oct 2022671228
Nov 2022751741
Dec 2022661831
Jan 2023482429
Feb 2023562732
Mar 2023911142
Apr 2023871441
May 2023541533
Jun 2023551414
Jul 2023341417
Aug 2023431919
Sep 2023461015
Oct 202351626
Nov 2023601913
Dec 202347312
Jan 202453418
Feb 202442718
Mar 2024392918
Apr 2024221014
May 2024191918
Jun 20242167
Jul 2024281016
Aug 2024192125
Sep 2024301110
Oct 202417345
Nov 202421619
Dec 2024243
Back to top
Posted January 17, 2022.
Download PDF
Data/Code
Email
Clinical Utility of Combined Optical Genome Mapping and 523-gene Next Generation Sequencing Panel For Comprehensive Evaluation of Myeloid Cancers
Nikhil Shri Sahajpal, Ashis K Mondal, Sudha Ananth, Daniel Saul, Soheil Shams, Alex R Hastie, Natasha M. Savage, Vamsi Kota, Alka Chaubey, Ravindra Kolhe
medRxiv 2022.01.15.22269355; doi: https://doi.org/10.1101/2022.01.15.22269355
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area